{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:37:30Z","timestamp":1790753850386,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T00:00:00Z","timestamp":1623110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.rgmxen.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T08:08:47Z","timestamp":1624090127000},"page":"265-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review"],"prefix":"10.1016","volume":"86","author":[{"given":"R.","family":"Contreras-Oma\u00f1a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.E.","family":"Escorcia-Saucedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Velarde-Ruiz Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2021.06.004_bib0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMp1408040","article-title":"Antibiotic resistance-problems, progress, and prospects","volume":"371","author":"Carl","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1056\/NEJMe1108464","article-title":"What has kept the antibiotic miracle alive?","volume":"365","author":"Thomas","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.17843\/rpmesp.2018.351.3594","article-title":"Antimicrobial resistance: A new approach and opportunity","volume":"35","author":"Yagui","year":"2018","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0020","first-page":"1","article-title":"Reflexiones sobre la resistencia antibi\u00f3ticos y qu\u00e9 hacer al respecto","volume":"81","author":"Remes Troche","year":"2016","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0025","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori therapy for the prevention of metachronous gastric cancer","volume":"378","author":"Il Ju","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0030","first-page":"325","article-title":"IV consenso mexicano sobre Helicobacter pylori","volume":"83","author":"Bosques-Padilla","year":"2018","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0035","first-page":"16","article-title":"El abordaje, las actitudes y el conocimiento acerca de Helicobacter pylori en m\u00e9dicos generales es deficiente. \u00a1Hay mucho que mejorar!","volume":"83","author":"Cano-Contreras","year":"2018","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0040","first-page":"114","article-title":"Frecuencia de errdiaci\u00f3n del Helicobacter pylori con triple esquema convencional en pacientes adultos del Centro M\u00e9dico Issemym","volume":"77","author":"Gonz\u00e1lez-Huezo","year":"2012","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0045","first-page":"274","article-title":"Erradiaci\u00f3n de Helicobacter pylori en M\u00e9xico con un esquema basado en levofloxacina versus la triple terapia est\u00e1ndar: resultados de un estudio cl\u00ednico de fase iiib, abierto, aleatorizado, de no inferioirdad","volume":"84","author":"Ladr\u00f3n de Guevara","year":"2019","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0050","doi-asserted-by":"crossref","first-page":"16245","DOI":"10.3748\/wjg.v20.i43.16245","article-title":"Langn Different antibiotic susceptibility between antrum and corpus of the stomach, a possible reason for treatment failure of Helicobacter pylori infection","volume":"20","author":"Selgrad","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0055","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1590\/s1678-9946201860025","article-title":"The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori","volume":"60","author":"Vianna","year":"2018","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0060","first-page":"306","article-title":"Helicobacter pylori infection: Antibiotic resistance and eradication rate in patients with gastritis showing previous treatment failures","volume":"41","author":"Mascellino","year":"2018","journal-title":"New Microbiol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ajg.2014.24","article-title":"The problem of Helicobacter pylori resistance to antibiotics: a systematic review in Latin America","volume":"109","author":"Carmargo","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0070","doi-asserted-by":"crossref","first-page":"13432","DOI":"10.3748\/wjg.v21.i48.13432","article-title":"High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment","volume":"21","author":"Zhang","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2016-312288","article-title":"Management of Helicobacter pylori infection-the Maastricht V\/Florence Consensus Report","volume":"66","author":"Malfertheiner","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0080","first-page":"41","article-title":"Perspectivas hist\u00f3ricas y vigentes sobre la infecci\u00f3n por Clostridium difficile","volume":"83","author":"\u00c1lvarez.Hern\u00e1ndez","year":"2018","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0085","first-page":"371","article-title":"Factors associated with Clostridium difficile disease in a tertiary-care medical institution in Mexico: A case-control study","volume":"61","author":"Camacho-Ortiz","year":"2009","journal-title":"Rev Invest Clin"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0090","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5414\/CN109387","article-title":"Clostridium difficile infection in patients with chronic kidney disease in Mexico","volume":"90","author":"Morfin-Otero","year":"2018","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0095","first-page":"227","article-title":"Diarrea asociada a Clostridioides difficile en pacientes de servicios quir\u00fargicos en M\u00e9xico","volume":"85","author":"Morf\u00edn-Otero","year":"2020","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0100","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijid.2016.11.346","article-title":"The third Clostridium difficile NAP\/BI\/027 strain outbreak in Mexico","volume":"53","author":"Rodriguez","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infections in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA).","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0110","first-page":"204","article-title":"Consenso sobre prevenci\u00f3n, diagn\u00f3stico y tratamiento de la infecci\u00f3n por Clostridium difficile","volume":"84","author":"Abreu y Abreu","year":"2019","journal-title":"Rev Gastroenterol M\u00e9x"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0115","first-page":"1","article-title":"Clostridioides difficile therapeutics: Guidelines and beyond","volume":"6","author":"Orenstein","year":"2019","journal-title":"Ther Adv Infectious Dis"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jiac.2020.02.014","article-title":"Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile","volume":"26","author":"Hamada","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0125","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jiph.2020.01.154","article-title":"Antimicrobials for treating Clostridium difficile infections","volume":"13","author":"Sridharan","year":"2020","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0130","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/cid\/ciu313","article-title":"Vancomycin, metronidazole, or tolevamer for Clostridium difficile Infection: Results from two multinational, randomized, controlled trials","volume":"59","author":"Jonhson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0135","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1128\/JCM.02250-16","article-title":"Update on antimicrobial resistance in Clostridium difficile: Resistance mechanisms and antimicrobial susceptibility testing","volume":"55","author":"Peng","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0140","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/mdr.2017.0323","article-title":"Circulation of highly drug-resistant Clostridium difficile ribotypes 027 and 001 in two tertiary-care hospitals in Mexico","volume":"24","author":"Mart\u00ednez-Mel\u00e9ndez","year":"2018","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4067\/s0716-10182018000200213","article-title":"Prevalencia y caracterizaci\u00f3n del perfil de susceptibilidad antimicrobiana de Campylobacter jejuni y Campylobacter coli en ni\u00f1os con diarrea de la ciudad de Loja, Ecuador","volume":"35","author":"Simaluiza","year":"2018","journal-title":"Rev Chil Infectol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4067\/S0301-732X2016000300002","article-title":"Campylobacter: fluoroquinolone resistance in Latin-American countries","volume":"48","author":"Fern\u00e1ndez","year":"2016","journal-title":"Arch Med Vet"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0155","first-page":"115","article-title":"Antimicrobial susceptibility profile of enterotoxigenic and enteropathogenic Escherichia coli isolates obtained from fecal specimens of children with acute diarrhea","volume":"53","author":"Oliveira","year":"2017","journal-title":"J Bras Patol Med Lab"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1590\/S0036-46652014000400012","article-title":"Antimicrobial drug resistance in strains of Escherichia coli isolated from food sources","volume":"56","author":"Rasheed","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/19476330903119234","article-title":"Presence and antimicrobial resistance of Escherichia coli isolated from foodstuffs in Hidalgo State (Mexico)","volume":"8","author":"Miranda","year":"2010","journal-title":"CyTA-Journal of Food"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0170","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pt.2012.05.001","article-title":"Blastocystis: Past pitfalls and future perspectives","volume":"28","author":"Scanlan","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0175","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.parint.2016.01.010","article-title":"Eradication of Blastocystis in humans: Really necessary for all?","volume":"65","author":"Kurt","year":"2016","journal-title":"Parasitol Int"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212542","article-title":"Resistance toward metronidazole in Blastocystis sp.: A pathogenic consequence","volume":"14","author":"Rajamanikam","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.gastrohep.2016.11.003","article-title":"Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review","volume":"40","author":"Batista","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4067\/S0034-98872008000100015","article-title":"Historia del protozoo Entamoeba histolytica","volume":"136","author":"Pinilla","year":"2008","journal-title":"Rev M\u00e9d Chile"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0195","series-title":"Prevalence in Entamoeba histolytica infection","first-page":"93","author":"Walsh","year":"1988"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1086\/313433","article-title":"Entamoeba histolytica and Entamoeba dispar: Epidemiology and comparison of diagnostic methods in a setting of nonendemicity","volume":"29","author":"Pillai","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-4894(88)90095-1","article-title":"Entamoeba histolytica: Virulence potential and sensitivity to metronidazole and emetine of four isolate possessing nonpathogenic zymodemes","volume":"66","author":"Burchard","year":"1988","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0210","first-page":"115","article-title":"Drug resistance in amoebiasis","volume":"123","author":"Bansal","year":"2006","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0215","doi-asserted-by":"crossref","first-page":"26051","DOI":"10.1074\/jbc.274.37.26051","article-title":"Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase","volume":"274","author":"Wassmann","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0220","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.trstmh.2007.04.001","article-title":"Nitazoxanide in the treatment of amoebiasis","volume":"101","author":"Rossignol","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0225","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0230","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.3748\/wjg.v20.i39.14079","article-title":"Multi-resistant bacteria in spontaneous bacterial peritonitis: A new step in management?","volume":"20","author":"Alves de Mattos","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0235","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/eci.12701","article-title":"Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis","volume":"47","author":"Lutz","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0240","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.3748\/wjg.v23.i25.4654","article-title":"Nosocomial spontaneous bacterial peritonitis antibiotic treatment in the era of multi-drug resistance pathogens: A systematic review","volume":"23","author":"Fiore","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0245","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/hep.27941","article-title":"The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial","volume":"63","author":"Piano","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0250","doi-asserted-by":"crossref","first-page":"10409","DOI":"10.3748\/wjg.v21.i36.10409","article-title":"Pathogen profile and drug resistance analysis of spontaneous peritonitis in cirrhotic patients","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rgmxen.2021.06.004_bib0255","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.4081\/idr.2015.6286","article-title":"The possible role of anti-methicillin-resistant Staphylococcus aureus antimicrobial agents in spontaneous bacterial peritonitis","volume":"7","author":"Fiore","year":"2015","journal-title":"Infect Dis Rep"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X21000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X21000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:52:41Z","timestamp":1762419161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X21000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2255534X21000633"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2021.06.004","relation":{},"ISSN":["2255-534X"],"issn-type":[{"value":"2255-534X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2021.02.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}